SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------------------------
FORM 11-K
ANNUAL REPORT
PURSUANT TO SECTION 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
(Mark One:)
[x] ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934 (NO FEE REQUIRED)
For the fiscal year ended December 31, 2001
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934 (NO FEE REQUIRED)
For the transition period from ____________ to ____________
Commission file number: 000-21326
A. Full title of the plan and the address of the plan, if different from
that of the issuer named below:
Anika Therapeutics, Inc.
Employee Savings and Retirement Plan
B. Name of issuer of the securities held pursuant to the plan and the
address of its principal executive office:
Anika Therapeutics, Inc.
236 West Cummings Park
Woburn, MA 01801
(781) 932-6616
REQUIRED INFORMATION
Item 4. Plan financial statements and schedule for the year ended December 31,
2001 have been prepared in accordance with the financial reporting requirements
of ERISA.
PAGE NUMBER
IN THIS REPORT
--------------
Statements of Net Assets Available for Benefits as of December 31, 2001
and 2000 F-1
Statement of Changes in Net Assets Available for Benefits for
the year ended December 31, 2001 F-2
Signature
THE PLAN. Pursuant to the requirements of the Securities Exchange Act
of 1934, the trustees have duly caused this annual report to be signed on their
behalf by the undersigned hereunto duly authorized.
Anika Therapeutics, Inc.
Employee Savings and Retirement Plan
By: /s/ Douglas R. Potter
-----------------------------------
Douglas R. Potter, Trustee
Dated: June 27, 2002
Anika Therapeutics, Inc.
Employee Savings & Retirement Plan
STATEMENTS OF NET ASSETS AVAILABLE FOR BENEFITS
AS OF DECEMBER 31, 2001 and 2000
2001 2000
INVESTMENTS
Participant directed, at fair value -
Money market fund $ 297,788 $ 193,325
Employer common stock 68,422 57,259
Mutual funds 1,229,504 1,238,389
Participant loans 84,839 100,074
---------- ----------
Total investments 1,680,553 1,589,047
CONTRIBUTIONS RECEIVABLE 22,396 13,556
---------- ----------
NET ASSETS AVAILABLE FOR BENEFITS $1,702,949 $1,602,603
========== ==========
F-1
Anika Therapeutics, Inc.
Employee Savings & Retirement Plan
STATEMENT OF CHANGES IN NET ASSETS AVAILABLE FOR BENEFITS
FOR THE YEAR ENDED DECEMBER 31, 2001
2001
Interest & dividends $ 44,430
----------
Contributions by:
Employees 296,121
Employer 186,870
Rollover distributions, net (7,594)
----------
Total contributions 475,397
----------
Total additions 519,827
----------
Less:
Distributions to former participants 215,187
----------
Net increase (decrease) before realized gains and losses 304,640
Net realized and unrealized investment gains and losses (204,294)
----------
Net decrease in net assets 100,346
Net assets available for benefits, beginning of year 1,602,603
----------
Net assets available for benefits, end of year $1,702,949
==========
F-2